[1]
Abdalnaser K. A. Al-Zahrawi and Firas Faris Rija 2023. Assessment Of Serum Levels of Zeb2 and Fat10 and Tumor Necrosis Factor-Alpha as Potential Novel Biomarkers in Breast Cancer Patients. Journal of Population Therapeutics and Clinical Pharmacology. 30, 5 (Mar. 2023), 366–371. DOI:https://doi.org/10.47750/jptcp.2023.30.05.037.